{"id":30886,"date":"2022-11-02T17:45:00","date_gmt":"2022-11-02T16:45:00","guid":{"rendered":"https:\/\/www.transgene.com\/?p=30886"},"modified":"2026-07-09T15:23:03","modified_gmt":"2026-07-09T13:23:03","slug":"transgene-annonce-le-resultat-positif-de-lanalyse-intermediaire-de-lessai-de-phase-ii-evaluant-tg4001-avelumab-vs-avelumab-seul-dans-les-cancers-anogenitaux-hpv-positifs","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/transgene-annonce-le-resultat-positif-de-lanalyse-intermediaire-de-lessai-de-phase-ii-evaluant-tg4001-avelumab-vs-avelumab-seul-dans-les-cancers-anogenitaux-hpv-positifs\/","title":{"rendered":"Transgene annonce le r\u00e9sultat positif de l&rsquo;analyse interm\u00e9diaire de l&rsquo;essai de Phase II \u00e9valuant TG4001 + Avelumab vs Avelumab seul dans les cancers anog\u00e9nitaux HPV-positifs"},"content":{"rendered":"\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n\n\n\n<p class=\"eplus-DVrMbh\"><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20221102_-_TG4001_Interim_Analysis_-_FR.pdf\">Transgene annonce le r\u00e9sultat positif de l&rsquo;analyse interm\u00e9diaire de l&rsquo;essai de Phase II \u00e9valuant TG4001<\/a><\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp; Transgene annonce le r\u00e9sultat positif de l&rsquo;analyse interm\u00e9diaire de l&rsquo;essai de Phase II \u00e9valuant TG4001<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[135,11,23,94],"tags":[],"class_list":["post-30886","post","type-post","status-publish","format-standard","hentry","category-135","category-press-release-fr","category-tg4001-fr","category-tg4001-ok","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"nh","author_link":"https:\/\/www.transgene.com\/fr\/author\/nh\/"},"uagb_comment_info":0,"uagb_excerpt":"&nbsp; &nbsp; Transgene annonce le r\u00e9sultat positif de l&rsquo;analyse interm\u00e9diaire de l&rsquo;essai de Phase II \u00e9valuant TG4001","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/30886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=30886"}],"version-history":[{"count":1,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/30886\/revisions"}],"predecessor-version":[{"id":41545,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/30886\/revisions\/41545"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=30886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=30886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=30886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}